VTRS logo

Viatris (VTRS)

Profile

Full Name

Viatris Inc.

Ticker Symbol

VTRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.viatris.com

Employees

32000

Key Details

Price

$7.48(-1.97%)

Market cap

$8.93B(Mid cap)

Last Dividend

$0.12

TTM Dividend yield

6.42%

Annual revenue

$14.74B(-4.46% YoY)

Annual EPS

-$0.53(-1160.00% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.48
VTRS price is $7.48

30-Day Relative Volume

0.67
VTRS 30-day relative volume is 0.67

Price Performance

Price Today change

-1.97%
VTRS price is down -1.97% today

Price YTD change

-39.92%
VTRS price is down -39.92% since January 1st

Price 1-year change

-33.92%
VTRS price is down -33.92% year-on-year

Price 3-year change

-31.75%
VTRS price is down -31.75% over the past 3 years

Price Range

Price All-time high

$76.69
VTRS price is currently -90.25% below its historical high of $76.69

Price 3-year low

$6.85
VTRS price is currently +9.20% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.93B
VTRS market capitalization is $8.93 billion

Market cap 3-year change

-32.8%
VTRS market capitalization is down -32.8% over the past 3 years

Market cap All-time high

$37.23B
VTRS market capitalization is currently -76.02% below its historical high of $37.23 billion

Market cap sector rank

92.02%
VTRS market capitalization is higher than 92.02% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.28%
VTRS shares outstanding is up +0.28% year-on-year

Shares Outstanding 3-Year Change

-1.54%
VTRS shares outstanding is down -1.54% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.69
VTRS beta is 0.69

200-day SMA

$11.26
VTRS price is currently -33.55% below its 200-day simple moving average

50-day SMA

$9.47
VTRS price is currently -20.98% below its 50-day simple moving average

RSI

31.91
VTRS 14-day relative strength index is 31.91

Volume

0.67
VTRS 30-day relative volume is 0.67

ATR

$0.42
VTRS average true range is $0.42

10-day Historical Volatility

69.42%
VTRS 10-day historical volatility is 69.42%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.12
VTRS last dividend was $0.12 per share, with an ex-dividend date of March 10, 2025

Next Dividend

-
VTRS next dividend has not yet been announced

Dividend per share

Dividend per share

$0.48
VTRS annual dividend per share is $0.48

Dividend per share Sector Rank

20.93%
VTRS annual dividend per share is higher than 20.93% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
VTRS {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

+45.45%
VTRS annual dividend per share is up +45.45% over the past 3 years

Dividend yield

Dividend yield

6.42%
VTRS annual dividend yield is 6.42%

Dividend yield Sector Rank

88.24%
VTRS annual dividend yield is higher than 88.24% of companies in Healthcare sector

Other

Payout ratio

-90.63%
VTRS annual payout ratio is -90.63%

Dividends paid

$574.80M
VTRS annual dividends paid is $574.80 million

Free cash flow

$1.94B
VTRS annual free cash flow is $1.94 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$14.74B
VTRS annual revenue is $14.74 billion

Revenue Analysts estimate

$13.79B
VTRS annual revenue is currently +6.86% higher than the consensus analysts' forecast

Revenue 1-year change

-4.46%
VTRS annual revenue is down -4.46% year-on-year

Revenue Sector rank

95.52%
VTRS annual revenue is higher than 95.52% of companies in Healthcare sector

EPS

EPS

-$0.53
VTRS annual earnings per share is -$0.53

EPS Analysts estimate

$2.20
VTRS annual earnings per share is currently -124.04% lower than the consensus analysts' forecast

EPS 1-year change

-1160%
VTRS annual earnings per share is down -1160% year-on-year

EPS Sector rank

67.82%
VTRS annual earnings per share is higher than 67.82% of companies in Healthcare sector

Profit

Gross profit

$5.62B
VTRS annual gross profit is $5.62 billion

Gross margin

38.15%
VTRS annual gross profit margin is 38.15%

Operating profit

$389.30M
VTRS annual operating income is $389.30 million

Operating margin

2.64%
VTRS annual operating profit margin is 2.64%

Net income

-$634.20M
VTRS annual net profit is -$634.20 million

Net margin

-4.30%
VTRS annual net profit margin is -4.30%

Expenses

Total expenses

$14.35B
VTRS annual total expenses is $14.35 billion

Operating expenses

$5.23B
VTRS annual total operating expenses is $5.23 billion

Cost of goods sold

$9.12B
VTRS annual cost of goods sold is $9.12 billion

Selling, general & administrative expenses

$4.43B
VTRS annual SGA is $4.43 billion

Depreciation and amortization

$2.89B
VTRS annual depreciation & amortization is $2.89 billion

Interest expense

$550.00M
VTRS annual interest expense is $550.00 million

Income tax

$11.00M
VTRS annual income tax is $11.00 million

EBIT & EBITDA

EBIT

-$73.20M
VTRS annual earnings before interest & taxes is -$73.20 million

EBITDA

-$73.20M
VTRS annual EBITDA is -$73.20 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$41.50B
VTRS annual total assets is $41.50 billion

Non current assets

$31.98B
VTRS annual long term assets is $31.98 billion

Current assets

$9.52B
VTRS annual total current assets is $9.52 billion

Cash and cash equivalents

$734.80M
VTRS annual cash & cash equivalents is $734.80 million

Accounts receivable

$2.68B
VTRS annual accounts receivable is $2.68 billion

Inventory

$3.85B
VTRS annual inventory is $3.85 billion

Liabilities

Total liabilities

$22.87B
VTRS annual total liabilities is $22.87 billion

Long term liabilities

$17.09B
VTRS annual total long term liabilities is $17.09 billion

Current liabilities

$5.78B
VTRS annual total current liabilities is $5.78 billion

Accounts payable

$1.36B
VTRS annual accounts payable is $1.36 billion

Debt

Total debt

$14.13B
VTRS annual total debt is $14.13 billion

Total debt 1-year change

-23.1%
VTRS annual total debt is down -23.1% year-on-year

Long term debt

$14.04B
VTRS annual long term debt is $14.04 billion

Short term debt

$87.70M
VTRS annual short term debt is $87.70 million

Equity & Capital

Shareholders equity

$18.64B
VTRS annual stockholders equity is $18.64 billion

Book value

$18.64B
VTRS annual book value is $18.64 billion

Retained earnings

$3.42B
VTRS annual retained earnings is $3.42 billion

Working capital

$3.74B
VTRS annual working capital is $3.74 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$2.30B
VTRS annual cash flow from operations is $2.30 billion

Cash from operations 1-year change

-20.59%
VTRS annual cash flow from operations is down -20.59% year-on-year

Cash from investing

$1.80B
VTRS annual cash flow from investing activities is $1.80 billion

Cash from investing 1-year change

+308.29%
VTRS annual cash flow from investing activities is up +308.29% year-on-year

Cash from financing

-$4.33B
VTRS annual cash flow from financing activities is -$4.33 billion

Cash from financing 1-year change

-88.12%
VTRS annual cash flow from financing activities is down -88.12% year-on-year

CAPEX

CAPEX

$359.10M
VTRS annual capital expenditures is $359.10 million

CAPEX 1-year change

-37.54%
VTRS annual capital expenditures is down -37.54% year-on-year

Free Cash Flow

Free cash flow

$1.94B
VTRS annual free cash flow is $1.94 billion

Free cash flow 1-year change

-16.4%
VTRS annual free cash flow is down -16.4% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

38.15%
VTRS annual gross profit margin is 38.15%

Operating margin

2.64%
VTRS annual operating profit margin is 2.64%

Net margin

-4.30%
VTRS annual net profit margin is -4.30%

ROA & ROE

ROA

-1.42%
VTRS annual return on assets is -1.42%

ROE

-3.24%
VTRS annual return on equity is -3.24%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VTRS price to earnings ratio value is unknown

PE ratio Sector rank

-
VTRS price to earnings ratio is unknown

PB Ratio

PB ratio

0.48
VTRS price to book ratio is 0.48

PB ratio Sector rank

29.05%
VTRS price to book ratio is higher than 29.05% of companies in Healthcare sector

PS Ratio

PS ratio

0.61
VTRS price to sales ratio is 0.61

PS ratio Sector rank

19.74%
VTRS price to sales ratio is higher than 19.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$22.50B
VTRS enterprise value is $22.50 billion

Enterprise value Sector rank

95.29%
VTRS enterprise value is higher than 95.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.85
VTRS EV/EBITDA is 10.85

EV/EBITDA Sector rank

83.39%
VTRS EV/EBITDA is higher than 83.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.65
VTRS annual current ratio is 1.65

Quick ratio

0.98
VTRS annual quick ratio is 0.98

Leverage

Debt to equity

0.75
VTRS annual debt to equity ratio is 0.75

Interest coverage ratio

-0.13
VTRS annual interest coverage ratio is -0.13

Risk & Stability

Piotroski F-Score

5
VTRS piotroski f-score is 5

Altman Z-Score

0.81
VTRS altman z-score is 0.81

Analyst ratings

Recent major analysts updates

Mar 7, 25 Jefferies
Buy
Mar 5, 25 Piper Sandler
Neutral
Feb 28, 25 Barclays
Underweight
Feb 28, 25 B of A Securities
Underperform
Dec 6, 24 Piper Sandler
Neutral
Nov 8, 24 Barclays
Underweight
Mar 28, 24 Piper Sandler
Neutral
Nov 22, 23 Piper Sandler
Neutral
Oct 23, 23 B of A Securities
Underperform
Jun 23, 23 Barclays
Underweight

Institutional Ownership

Similar stocks

QGEN logo
Qiagen NV (QGEN)
CHE logo
Chemed (CHE)
ASND logo
Ascendis Pharma A/S (ASND)
MEDP logo
Medpace Holdings (MEDP)
WBA logo
Walgreens Boots Alliance (WBA)
ATR logo
AptarGroup (ATR)
NBIX logo
Neurocrine Biosciences (NBIX)
MASI logo
Masimo (MASI)
EXAS logo
Exact Sciences (EXAS)
  • What is the ticker symbol for Viatris?
  • Does Viatris pay dividends?
  • What sector is Viatris in?
  • What industry is Viatris in?
  • What country is Viatris based in?
  • When did Viatris go public?
  • Is Viatris in the S&P 500?
  • Is Viatris in the NASDAQ 100?
  • Is Viatris in the Dow Jones?
  • When was Viatris's last earnings report?
  • When does Viatris report earnings?
  • Should I buy Viatris stock now?

What is the ticker symbol for Viatris?

The ticker symbol for Viatris is NASDAQ:VTRS

Does Viatris pay dividends?

Yes, Viatris pays dividends. The last payment was $0.12, with an ex-dividend date on March 10, 2025

What sector is Viatris in?

Viatris is in the Healthcare sector

What industry is Viatris in?

Viatris is in the Drug Manufacturers - Specialty & Generic industry

What country is Viatris based in?

Viatris is headquartered in United States

When did Viatris go public?

Viatris's initial public offering (IPO) was on March 17, 1980

Is Viatris in the S&P 500?

Yes, Viatris is included in the S&P 500 index

Is Viatris in the NASDAQ 100?

No, Viatris is not included in the NASDAQ 100 index

Is Viatris in the Dow Jones?

No, Viatris is not included in the Dow Jones index

When was Viatris's last earnings report?

Viatris's most recent earnings report was on Feb 27, 2025

When does Viatris report earnings?

The next expected earnings date for Viatris is May 8, 2025

Should I buy Viatris stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page